Adenocard Related Published Studies
Well-designed clinical trials related to Adenocard (Adenosine)
Preconditioning effects of adenosine in patients with severe coronary artery disease but preserved coronary flow reserve. [2009.08]
Effect of adenosine 5'-triphosphate infusions on the nutritional status and survival of preterminal cancer patients. [2009.08]
Adenosine modulates oesophageal sensorimotor function in humans. [2009.08]
Randomized evaluation of intracoronary nitroprusside vs. adenosine after thrombus aspiration during primary percutaneous coronary intervention for the prevention of no-reflow in acute myocardial infarction: the REOPEN-AMI study protocol. [2009.07]
Application of a shortened inhaled adenosine-5'-monophosphate challenge in young children using the forced oscillation technique. [2009.07]
Rosuvastatin increases extracellular adenosine formation in humans in vivo: a new perspective on cardiovascular protection. [2009.06]
Maximal response plateau to adenosine 5'-monophosphate in asthma. Relationship with the response to methacholine, exhaled nitric oxide, and exhaled breath condensate pH. [2009.06]
Slow infusion of calcium channel blockers compared with intravenous adenosine in the emergency treatment of supraventricular tachycardia. [2009.05]
Head to head comparisons of two modalities of perfusion adenosine stress echocardiography with simultaneous SPECT. [2009.04.20]
Plaque retention by self-ligating vs elastomeric orthodontic brackets: quantitative comparison of oral bacteria and detection with adenosine triphosphate-driven bioluminescence. [2009.04]
Differences in heart rate response to adenosine and regadenoson in patients with and without diabetes mellitus. [2009.04]
Effect of levocetirizine on nasal provocation testing with adenosine monophosphate compared with allergen challenge in allergic rhinitis. [2009.03]
No effect of nutritional adenosine receptor antagonists on exercise performance in the heat. [2009.02]
First-pass dynamic contrast-enhanced MRI with extravasating contrast reagent: evidence for human myocardial capillary recruitment in adenosine-induced hyperemia. [2009.02]
The RegEx trial: a randomized, double-blind, placebo- and active-controlled pilot study combining regadenoson, a selective A(2A) adenosine agonist, with low-level exercise, in patients undergoing myocardial perfusion imaging. [2009.01]
The myocardial protective effects of a moderate-potassium adenosine-lidocaine cardioplegia in pediatric cardiac surgery. [2008.12]
Phase 2, double-blind, placebo-controlled, dose-response trial of intravenous adenosine for perioperative analgesia. [2008.12]
Adenosine increases anagen hair growth and thick hairs in Japanese women with female pattern hair loss: a pilot, double-blind, randomized, placebo-controlled trial. [2008.12]
The PROTECT pilot study: a randomized, placebo-controlled, dose-finding study of the adenosine A1 receptor antagonist rolofylline in patients with acute heart failure and renal impairment. [2008.10]
Positron emission tomography analysis of [11C]KW-6002 binding to human and rat adenosine A2A receptors in the brain. [2008.09]
The reproducibility of adenosine monophosphate bronchial challenges in mild, steroid-naive asthmatics. [2008.08]
Safety of regadenoson, an adenosine A2A receptor agonist for myocardial perfusion imaging, in mild asthma and moderate asthma patients: a randomized, double-blind, placebo-controlled trial. [2008.05]
Safety of regadenoson, a selective adenosine A2A agonist, in patients with chronic obstructive pulmonary disease: A randomized, double-blind, placebo-controlled trial (RegCOPD trial). [2008.05]
Methacholine vs adenosine on intra and extrathoracic airway hyperresponsiveness in patients with cough variant asthma. [2008.05]
Hepatic fat and adenosine triphosphate measurement in overweight and obese adults using 1H and 31P magnetic resonance spectroscopy. [2008.05]
Effects of age, gender, obesity, and diabetes on the efficacy and safety of the selective A2A agonist regadenoson versus adenosine in myocardial perfusion imaging integrated ADVANCE-MPI trial results. [2008.05]
Adenosine A2A receptor antagonist istradefylline (KW-6002) reduces "off" time in Parkinson's disease: a double-blind, randomized, multicenter clinical trial (6002-US-005). [2008.03]
High dose adenosine for suboptimal myocardial reperfusion after primary PCI: A randomized placebo-controlled pilot study. [2008.02.15]
Clinical evidence for utilization of the A3 adenosine receptor as a target to treat rheumatoid arthritis: data from a phase II clinical trial. [2008.01]
Effect of an inhaled adenosine A2A agonist on the allergen-induced late asthmatic response. [2008.01]
Effects of airway anesthesia on dyspnea and ventilatory response to intravenous injection of adenosine in healthy human subjects. [2008]
Clinical Evidence for Utilization of the A3 Adenosine Receptor as a Target to Treat Rheumatoid Arthritis: Data from a Phase II Clinical Trial. [2007.11.15]
Safety, tolerability, and initial efficacy of AZD6140, the first reversible oral adenosine diphosphate receptor antagonist, compared with clopidogrel, in patients with non-ST-segment elevation acute coronary syndrome: primary results of the DISPERSE-2 trial. [2007.11.06]
Effect of hydroxyurea and dideoxyinosine on intracellular 3'-deoxyadenosine-5'-triphosphate concentrations in HIV-infected patients. [2007.11]
Adenosine versus regadenoson comparative evaluation in myocardial perfusion imaging: results of the ADVANCE phase 3 multicenter international trial. [2007.09]
Therapeutic benefit of low-dose clopidogrel in patients undergoing carotid surgery is linked to variability in the platelet adenosine diphosphate response and patients' weight. [2007.09]
Effects of multiple oral doses of an A1 adenosine antagonist, BG9928, in patients with heart failure: results of a placebo-controlled, dose-escalation study. [2007.08.14]
Effects of oral adenosine 5'-triphosphate and adenosine in enteric-coated capsules on indomethacin-induced permeability changes in the human small intestine: a randomized cross-over study. [2007.06.19]
Coronary circulation responses to binodenoson, a selective adenosine A2A receptor agonist. [2007.06.01]
Postconditioning the human heart with adenosine in heart valve replacement surgery. [2007.06]
Association between treatment-emergent suicidal ideation with citalopram and polymorphisms near cyclic adenosine monophosphate response element binding protein in the STAR*D study. [2007.06]
Formulation, characterization, and efficacy of an adenosine-containing dissolvable film for a localized anti-wrinkle effect. [2007.03]
Local effect of adenosine 5'-triphosphate on indomethacin-induced permeability changes in the human small intestine. [2007.03]
Application of adenosine 5'-triphosphate (ATP) infusions in palliative home care: design of a randomized clinical trial. [2007.01.08]
Adenosinergic mechanisms contribute to individual differences in sleep deprivation-induced changes in neurobehavioral function and brain rhythmic activity. [2006.10.11]
Transthoracic coronary flow velocity reserve assessment: comparison between adenosine and dobutamine. [2006.10]
Prospective, randomised, controlled trial to study the effect of intracoronary injection of verapamil and adenosine on coronary blood flow during percutaneous coronary intervention in patients with acute coronary syndromes. [2006.09]
Relationship between genetic variants in the adenosine pathway and outcome of methotrexate treatment in patients with recent-onset rheumatoid arthritis. [2006.09]
Post-reperfusion myocardial infarction: long-term survival improvement using adenosine regulation with acadesine. [2006.07.04]
Adenosine cardioprotection study in clinical setting of paroxysmal supraventricular tachycardia. [2006.06]
Efficacy of intrathecal adenosine for postoperative pain relief. [2006.06]
Quantitative adenosine real-time myocardial contrast echocardiography for detection of angiographically significant coronary artery disease. [2006.04]
Adenosine A1 receptor antagonist improves intradialytic hypotension. [2006.03]
Bolus injection of adenosine before cardioplegic induction improves postischemic global function in coronary artery bypass grafting. [2005.12]
Improvement in microvascular reflow and reduction of infarct size with adenosine in patients undergoing primary coronary stenting. [2005.11.15]
Left ventricular remodeling after primary coronary angioplasty in patients treated with abciximab or intracoronary adenosine. [2005.11]
Electrocardiographic infarct size assessment after thrombolysis: insights from the Acute Myocardial Infarction STudy ADenosine (AMISTAD) trial. [2005.10]
Role of adenosine and nitric oxide on the mechanisms of action of dipyridamole. [2005.10]
A randomized, double-blinded, placebo-controlled multicenter trial of adenosine as an adjunct to reperfusion in the treatment of acute myocardial infarction (AMISTAD-II). [2005.06.07]
Does adenosine pharmacologically precondition human myocardium during coronary bypass surgery? [2005.06]
The effect of circulating adenosine on cerebral haemodynamics and headache generation in healthy subjects. [2005.05]
High-dose adenosine infusion provokes oscillations of chest pain without correlation to opioid modulation: a double-blind controlled study. [2004.11]
Regulation of renal adenosine excretion in humans--role of sodium and fluid homeostasis. [2004.11]
Are high doses of intracoronary adenosine an alternative to standard intravenous adenosine for the assessment of fractional flow reserve? [2004.10]
The effect of intravenous infusion of adenosine on electrically evoked hyperalgesia in a healthy volunteer model of central sensitization. [2004.09]
Adenosine sestamibi SPECT post-infarction evaluation (INSPIRE) trial: A randomized, prospective multicenter trial evaluating the role of adenosine Tc-99m sestamibi SPECT for assessing risk and therapeutic outcomes in survivors of acute myocardial infarction. [2004.07]
Role of endogenous adenosine in atrial fibrillation after coronary artery bypass graft. [2004.06]
[Comparison of myocardial perfusion imaging by thallium-201 single-photon emission computed tomography with SUNY4001 (adenosine) and exercise--crossover clinical trial at multi-center] [2004.05]
Randomized, controlled dose-ranging study of the selective adenosine A2A receptor agonist binodenoson for pharmacological stress as an adjunct to myocardial perfusion imaging. [2004.02.03]
C-peptide improves adenosine-induced myocardial vasodilation in type 1 diabetes patients. [2004.01]
Combination of adenosine with prilocaine and lignocaine for brachial plexus block does not prolong postoperative analgesia. [2003.12]
Role of adenosine and opioid-receptor mechanisms for pain in patients with silent myocardial ischemia or angina pectoris: a double-blind, placebo-controlled study. [2003.12]
Perioperative intravenous adenosine infusion to extend postoperative analgesia in brachial plexus block. [2003.11]
[A randomized, multicenter trial to compare the safety and efficacy of adenosine versus verapamil for termination of paroxysmal supraventricular tachycardia] [2003.11]
Intrathecal, but not intravenous adenosine reduces allodynia in patients with neuropathic pain. [2003.09]
A randomized comparison of 4 doses of intracoronary adenosine in the assessment of fractional flow reserve. [2003.08]
A randomized, double-blinded, placebo-controlled, dose-ranging study measuring the effect of an adenosine agonist on infarct size reduction in patients undergoing primary percutaneous transluminal coronary angioplasty: the ADMIRE (AmP579 Delivery for Myocardial Infarction REduction) study. [2003.07]
Effects of adenosine on intraocular pressure, optic nerve head blood flow, and choroidal blood flow in healthy humans. [2003.07]
Adenosine treatment attenuates cytokine interleukin-6 responses to endotoxin challenge in healthy volunteers. [2003.06]
Intravenous adenosine alleviates neuropathic pain: a double blind placebo controlled crossover trial using an enriched enrolment design. [2003.05]
Left ventricular function and cardiovascular events following adjuvant therapy with adenosine in acute myocardial infarction treated with thrombolysis, results of the ATTenuation by Adenosine of Cardiac Complications (ATTACC) study. [2003.05]
Effect of the adenosine A1 receptor agonist GR79236 on trigeminal nociception with blink reflex recordings in healthy human subjects. [2003.05]
A randomised double-blind evaluation of adenosine as adjunct to sufentanil in spinal labour analgesia. [2003.05]
Characterization of the analgesic actions of adenosine: comparison of adenosine and remifentanil infusions in patients undergoing major surgical procedures. [2003.01]
The comparison of two gated SPET protocols: adenosine Tc-99m tetrofosmin and treadmill exercise Tc-99m MIBI. [2003]
Dose response of intrathecal adenosine in experimental pain and allodynia. [2002.10]
Urinary level of 1,N(6) -ethenodeoxyadenosine, a marker of oxidative stress, is associated with salt excretion and omega 6-polyunsaturated fatty acid intake in postmenopausal Japanese women. [2002.07.01]
Does a selective adenosine A(1) receptor agonist protect against exercise induced ischaemia in patients with coronary artery disease? [2002.02]
Increase of adenosine plasma levels after oral trimetazidine: a pharmacological preconditioning? [2002.01]
Preliminary efficacy assessment of intrathecal injection of an American formulation of adenosine in humans. [2002.01]
Assessment of adenosine, arbutamine and dobutamine as pharmacological stress agents during (99m)Tc-tetrofosmin SPECT imaging: a randomized study. [2001.12]
Effect of pravastatin on myocardial protection during coronary angioplasty and the role of adenosine. [2001.11.15]
Tolerance and diagnostic accuracy of an abbreviated adenosine infusion for myocardial scintigraphy: a randomized, prospective study. [2001.09]
Effect of systemic adenosine on pain and secondary hyperalgesia associated with the heat/capsaicin sensitization model in healthy volunteers. [2001.09]
Cardioprotective effect of adenosine pretreatment in coronary artery bypass grafting. [2001.09]
Randomized controlled trial of midazolam premedication to reduce the subjective adverse effects of adenosine. [2001.03]
Cilostazol (pletal): a dual inhibitor of cyclic nucleotide phosphodiesterase type 3 and adenosine uptake. [2001.01]
Pretreatment of human myocardium with adenosine. [2001.01]
Systemic adenosine infusion reduces the area of tactile allodynia in neuropathic pain following peripheral nerve injury: a multi-centre, placebo-controlled study. [2001]
Comparison of adenosine and exercise stress test for quantitative perfusion imaging in patients on beta-blocker therapy. [2001]
Adenosine A1 agonist at reperfusion trial (AART): results of a three-center, blinded, randomized, controlled experimental infarct study. [2000.12]
|
